Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine

Abstract

The long-acting dopamine agonist BC, by increasing dopaminergic tone, may influence body weight and likely body composition by mechanisms in addition to reducing hyperprolactinemia in patients with prolactinomas.